Back to top

BTIG Reiterates Buy Rating on SNDX with $56 Price Target | SNDX Stock News

BTIG Reiterates Buy Rating on SNDX with $56 Price Target | SNDX Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Syndax Pharmaceuticals, Inc. (SNDX)